Feeling ill on Mounjaro — what the evidence says and what to do

What the trial data tells us about feeling unwell

The SURMOUNT-1 study, which enrolled 2,539 adults with obesity over 72 weeks, documented gastrointestinal side effects in detail. Nausea affected roughly a third to half of participants depending on dose, diarrhoea was common at higher strengths, and constipation featured across the titration ladder. The pattern is consistent: symptoms cluster around the start of a new dose and tend to reduce significantly once the body acclimates, usually within one to two weeks. That's not a reason to dismiss them, but it is a reason not to panic.

Tirzepatide works partly by slowing how quickly food leaves the stomach. That gastric-emptying effect is central to how it reduces appetite, but it also explains why eating a large or fatty meal shortly before or after the injection often makes nausea worse. The medicine is doing what it's designed to do; the discomfort is a signal to adjust behaviour rather than stop treatment without speaking to a prescriber first. If you've been wondering about the intense fullness some people feel, it comes from the same mechanism.

Fatigue and mild headache also appear in trial data, particularly early on. These are lower-profile than the GI effects but worth flagging to your prescriber if they're affecting your daily life, especially if you've noticed unusual weakness alongside the tiredness.

The symptoms that need prompt attention

In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically addressing acute pancreatitis. The key warning: severe stomach pain that is persistent and may radiate to the back, with or without vomiting, should prompt you to stop the injection and seek urgent medical help. This is infrequent, but it can be serious, and it is not something to manage at home with antacids.

Other symptoms that should prompt a call to your GP or 111 rather than a wait:

Gallbladder-type pain (sharp, cramping upper-right abdominal pain, sometimes after eating) can indicate gallstones, which occur at slightly higher rates during significant weight loss. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) need emergency attention. And if vomiting or diarrhoea is prolonged enough that you can't keep fluids down, kidney function can be affected by dehydration; this is one reason the most common prescriber advice is to drink water consistently through the day, not in gulps when you remember.

Some people notice temperature changes alongside GI symptoms. If you're experiencing a pattern of unexplained chills or unusual warmth, read those pages, both can have straightforward explanations, but both are worth mentioning to your clinical team.

Practical things that genuinely help with mild nausea

A few adjustments make a real difference for mild to moderate nausea. Smaller, lower-fat meals reduce the stomach's workload when gastric emptying is already slowed. Eating slowly, stopping at the first sign of fullness (which on tirzepatide arrives earlier than you expect), and avoiding lying down immediately after meals all help. Cold or room-temperature food tends to produce fewer nausea cues than hot food for many people. Plain crackers, dry toast, and ginger in any form are time-honoured options.

Injection timing is another lever. Some people find that injecting at night means the peak nausea window passes while they're asleep. Others find a weekend morning works better, there's a reason our prescribers hear about the Monday-morning nausea that follows a Sunday-evening dose. Find the time that fits your week, not a textbook schedule.

Alcohol and very spicy food tend to amplify GI symptoms on any GLP-1 medicine. If you've been pairing your treatment with significant dietary changes, introduce those gradually rather than all at once. And if symptoms feel out of proportion to what's described here, that's a conversation to have, not something to push through silently. Our clinical team reviews every repeat before dispatch, and questions about tolerability are exactly the kind of thing aftercare is for. Separately, if you're weighing up how treatment costs fit your budget, the Mounjaro cost page explains what a legitimate private prescription actually includes.

Dizziness and other overlooked symptoms

Dizziness on tirzepatide sometimes accompanies nausea but can also arise independently, particularly if food and fluid intake have dropped sharply. Reduced calorie intake, especially if combined with not drinking enough, can cause postural dizziness (the lightheaded sensation when you stand quickly). Standing up slowly, maintaining hydration, and ensuring salt intake isn't too low are all simple adjustments. There's more on what causes dizziness specifically and when it warrants investigation.

Injection-site reactions (redness, mild swelling, brief itching at the site) are usually transient and managed by rotating the injection site between the abdomen, thigh, and upper arm. If a site reaction is spreading, warm to the touch, or not resolving within a few days, that's worth reporting. Patients and healthcare professionals can both report suspected side effects through the MHRA's Yellow Card scheme, it's how the safety picture for newer medicines stays current. Tirzepatide carries a Black Triangle (▼) designation, meaning extra MHRA monitoring applies while long-term data accumulates.

If you'd like to understand the medicine's broader profile before speaking to a prescriber, the tirzepatide overview and Mounjaro information page cover the mechanism, the licensing, and what clinical assessment involves.